IPR Strength
Significant breakthrough products:
- Cefixime Plus with Microencapsulation technology
- In-situ Gel Delivery System of Injectable Antibiotics
- Topical Delivery System of Injectable Antibiotics
Patents granted by the IPO
(We have international patents in pre-grant status for the same inventions)
- 10 Patents have been granted so far
- 5 Patents have been out-licensed so far.
Patents in pre-Grant status
- 30 divisional patents in Antidiabetic Therapy;
- 12 Patents in Antibiotics
- 48 divisional patents in Cardiovascular Therapy
- 10 divisional patents in Nutraceuticals